![]() |
|||
|
|
|
|
December 5, 2006 CDC Recommends Malaria Chemoprophylaxis For Travelers to Kingston, Jamaica AABB PulsePoints The Centers for Disease Control and Prevention (CDC) has notified AABB and other blood collection agencies that, until further notice, it is recommending malaria chemoprophylaxis for travelers who may stay overnight in Kingston, Jamaica. Travelers to other areas of the island do not need to take an antimalarial drug. This recommendation is expected to be temporary. AABB recommends potential blood donors who have traveled to Kingston, Jamaica, should be deferred for 12 months. Based on the likelihood that transmission first occurred in late October and to allow for the possibility that transmission could have occurred prior to the first detected case, deferral should be implemented as soon as possible for travel to Kingston, Jamaica, using a beginning travel date of Oct. 1, 2006. CDC took this precaution as a result of the following information it received from Ministry of Health of Jamaica and the Pan American Health Organization:
For further details, visit the CDC Web site at http://www.cdc.gov/travel/other/2006/malaria_jamaica.htm. -- End of AABB PulsePoints -- |
|||
|
Posted Dec. 5, 2006
|
|